Promethazine 25mg/ml Inj 1ml Vial

Manufacturer WEST-WARD Active Ingredient Promethazine Injection(proe METH a zeen) Pronunciation proe METH a zeen
WARNING: For all patients taking this drug:Severe tissue damage has happened with this drug. Sometimes, this has led to surgery. Tell your doctor or nurse right away if you have any burning, numbness, coldness, color changes (like skin turning red, purple, or black), pain, skin breakdown, pus, or swelling where the shot was given.This drug is injected into the muscle. Some doses may be given into a vein. This drug must not be injected into the fatty tissue under the skin or into an artery.Children:Do not give this drug to a child younger than 2 years of age. It may cause very bad and sometimes deadly breathing problems. Use with care in children 2 years of age and older. Talk with the doctor.Before your child takes this drug, tell the doctor if your child is taking any drugs that can cause breathing problems. There are many drugs that can do this. Ask the doctor or pharmacist if you are not sure. @ COMMON USES: It is used to ease allergy signs.It is used to help motion sickness.It is used to prevent upset stomach and throwing up from surgery.It is used during surgery.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihistamine, Antiemetic, Sedative
đŸ§Ŧ
Pharmacologic Class
Phenothiazine derivative, H1-receptor antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1951
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Promethazine is a medication that can help with nausea, vomiting, allergies, and can also make you feel sleepy. It works by blocking certain natural substances in your body. It's often used before surgery to help you relax or to help with motion sickness.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Administer the medication as directed, which may involve an intramuscular injection (a shot into a muscle) or an intravenous injection (a shot into a vein).

For proper storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep the medication at home.

If you miss a dose, contact your doctor promptly to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Avoid driving or operating heavy machinery until you know how this medication affects you, as it can cause significant drowsiness.
  • Avoid alcohol and other medications that cause drowsiness, as this can increase the sedative effects.
  • Stay hydrated to help with dry mouth, a common side effect.
  • If taking for motion sickness, take it at least 30-60 minutes before travel.
  • For injection, report any pain, burning, swelling, or redness at the injection site immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For nausea/vomiting: 12.5-25 mg IM/IV/PO every 4-6 hours as needed. For sedation: 25-50 mg IM/PO at bedtime or preoperatively. For allergic reactions: 25 mg IM/PO at bedtime or 12.5 mg IM/PO before meals and at bedtime.
Dose Range: 12.5 - 50 mg

Condition-Specific Dosing:

Nausea and Vomiting: 12.5-25 mg IM/IV/PO q4-6h PRN
Sedation: 25-50 mg IM/PO at bedtime or preoperatively
Allergic Reactions: 25 mg IM/PO at bedtime or 12.5 mg IM/PO before meals and at bedtime
Adjunct to Analgesia: 25-50 mg IM/IV with reduced dose of narcotic analgesic
đŸ‘ļ

Pediatric Dosing

Neonatal: Contraindicated in children < 2 years due to risk of fatal respiratory depression.
Infant: Contraindicated in children < 2 years due to risk of fatal respiratory depression.
Child: For children â‰Ĩ 2 years: 0.5 mg/kg IM/PO every 4-6 hours as needed for nausea/vomiting, not to exceed 25 mg per dose or 1.25 mg/kg per day. For sedation: 12.5-25 mg IM/PO at bedtime.
Adolescent: Same as adult dosing, generally 12.5-25 mg IM/IV/PO every 4-6 hours as needed.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but use with caution.
Moderate: No specific dose adjustment recommended, but use with caution.
Severe: No specific dose adjustment recommended, but use with caution. Monitor for increased sedation and anticholinergic effects.
Dialysis: Not significantly dialyzable. No specific dose adjustment recommended, but monitor closely.

Hepatic Impairment:

Mild: Use with caution. Consider lower doses.
Moderate: Use with caution. Consider lower doses and extended dosing intervals.
Severe: Use with caution. Significant hepatic impairment may lead to increased plasma levels and prolonged effects. Consider lower doses and extended dosing intervals.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Promethazine is a phenothiazine derivative that acts as a potent, competitive H1-receptor antagonist. It also possesses significant anticholinergic (muscarinic), antidopaminergic, and alpha-adrenergic blocking activity. Its antiemetic effects are thought to be due to its anticholinergic and antidopaminergic actions, particularly blocking dopamine D2 receptors in the chemoreceptor trigger zone (CTZ). Its sedative effects are due to its H1-blocking and anticholinergic properties.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (oral, IM); IV is 100%
Tmax: Oral: 2-3 hours; IM: 20-60 minutes; IV: Rapid
FoodEffect: Food may delay absorption but does not significantly affect bioavailability.

Distribution:

Vd: 131-177 L (large volume of distribution)
ProteinBinding: Approximately 93% (to plasma proteins)
CnssPenetration: Yes (readily crosses blood-brain barrier)

Elimination:

HalfLife: Oral: 10-14 hours (range 7-19 hours); IM/IV: 9-16 hours
Clearance: Not available
ExcretionRoute: Primarily renal (urine) as inactive metabolites; small amount in feces.
Unchanged: <1% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Oral: 20-60 minutes; IM: 20 minutes; IV: 3-5 minutes
PeakEffect: Oral: 2-3 hours; IM: 30-60 minutes; IV: 5-10 minutes
DurationOfAction: 4-6 hours (can be up to 12 hours for sedative effects)
Confidence: High

Safety & Warnings

âš ī¸

BLACK BOX WARNING

RESPIRATORY DEPRESSION: Promethazine should not be used in pediatric patients less than 2 years of age because of the potential for fatal respiratory depression. Postmarketing cases of respiratory depression, including fatalities, have been reported with use of promethazine in pediatric patients less than 2 years of age. Caution should be exercised when administering promethazine to pediatric patients 2 years of age and older. A lower dose of promethazine should be used in pediatric patients 2 years of age and older. RISK OF SEVERE CHEMICAL IRRITATION AND DAMAGE TO TISSUES: Promethazine Injection is contraindicated for subcutaneous administration. Intra-arterial injection and perivascular extravasation can result in severe irritation and tissue damage, including gangrene requiring amputation. Preferred route of administration is deep intramuscular (IM) injection. When intravenous (IV) administration is necessary, it should be administered via a large-bore, patent vein, preferably through a central venous catheter, at a concentration not exceeding 25 mg/mL and at a rate not exceeding 25 mg/minute. Avoid veins in the hand or wrist. If extravasation occurs, immediately discontinue administration and manage as medically appropriate.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Abnormal heart rhythms, such as:
+ Fast or slow heartbeat
Neurological symptoms, including:
+ Trouble controlling body movements
+ Twitching
+ Changes in balance
+ Difficulty swallowing or speaking
+ Shakiness
+ Trouble moving around
+ Stiffness
Confusion or altered mental state
Feeling nervous or excitable
Hallucinations (seeing or hearing things that are not there)
Mood changes
Ringing in the ears
Seizures
Unexplained bruising or bleeding
Yellowing of the skin or eyes
* Changes in eyesight

Neuroleptic Malignant Syndrome (NMS): A rare but potentially life-threatening condition may occur. Seek immediate medical attention if you experience:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast or irregular heartbeat
+ Excessive sweating

Respiratory Problems: This medication may cause severe and potentially life-threatening breathing problems. Seek immediate medical attention if you experience:
+ Slow or shallow breathing
+ Difficulty breathing

Low White Blood Cell Count: This medication may increase the risk of infection due to a low white blood cell count. Seek immediate medical attention if you experience:
+ Fever
+ Chills
+ Sore throat

Other Side Effects

Most people do not experience severe side effects, and many may have only minor or no side effects at all. However, if you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or do not go away:
+ Dizziness
+ Drowsiness
+ Fatigue
+ Weakness
+ Blurred vision
+ Dry mouth
+ Upset stomach or vomiting
+ Trouble sleeping
+ Stuffy nose

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Difficulty breathing or very slow breathing
  • Severe drowsiness or difficulty waking up
  • Confusion or disorientation
  • Unusual muscle movements or stiffness (e.g., tremors, difficulty speaking, rigid muscles)
  • Severe dizziness or fainting
  • Yellowing of skin or eyes (jaundice)
  • Unusual bleeding or bruising
  • Pain, swelling, redness, or blistering at the injection site
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a history of respiratory problems, including:
+ Asthma
+ Chronic obstructive pulmonary disease (COPD)
+ Sleep apnea (breathing difficulties during sleep)
If you have a history of liver problems or Reye's syndrome.

This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor.

To ensure safe treatment, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
Your complete medical history, including any health problems you have or have had

Do not start, stop, or modify the dosage of any medication without first consulting your doctor to confirm that it is safe to do so in conjunction with this medication.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness or clear vision, such as driving, wait until you understand how this drug affects you.

This medication may interfere with the accuracy of certain pregnancy tests. If you are pregnant or suspect you may be pregnant, consult your doctor. Additionally, if you have diabetes, it is crucial to closely monitor your blood sugar levels while taking this medication.

Before consuming alcohol, using marijuana or other cannabis products, or taking prescription or over-the-counter medications that may impair your reactions, discuss the potential risks with your doctor.

You may be more susceptible to sunburn while taking this medication. To minimize this risk, avoid exposure to direct sunlight, sunlamps, and tanning beds. Use protective measures such as sunscreen, clothing, and eyewear that shield you from the sun.

This medication may increase the risk of seizures, particularly in individuals with a history of seizure disorders. Consult your doctor to determine if you are at a higher risk of experiencing seizures while taking this medication.

If you have a sulfite allergy, inform your doctor, as some formulations of this medication may contain sulfites.

Individuals 65 years or older should exercise caution when taking this medication, as they may be more prone to experiencing side effects.

If you are pregnant, planning to become pregnant, or breastfeeding, it is essential to discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Respiratory depression (slow, shallow breathing)
  • Hypotension (low blood pressure)
  • Tachycardia (fast heart rate)
  • Anticholinergic effects (dilated pupils, dry mouth, flushed skin, fever, urinary retention, paralytic ileus)
  • Seizures
  • Extrapyramidal symptoms
  • Cardiovascular collapse

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining airway, assisting ventilation, managing hypotension, and controlling seizures. Physostigmine may be considered for severe anticholinergic symptoms. Avoid analeptics (CNS stimulants).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • MAO inhibitors (concurrent use or within 14 days of promethazine)
  • Other CNS depressants (in children < 2 years due to increased risk of respiratory depression)
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, some antipsychotics, macrolide antibiotics, fluoroquinolones) - theoretical risk of additive QT prolongation
🔴

Major Interactions

  • CNS depressants (opioids, benzodiazepines, barbiturates, alcohol, other antihistamines, general anesthetics): Additive CNS depression, respiratory depression, profound sedation.
  • Anticholinergic drugs (e.g., tricyclic antidepressants, atropine, benztropine): Additive anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation, paralytic ileus).
  • Dopamine agonists (e.g., bromocriptine, cabergoline): Promethazine's antidopaminergic effects may antagonize their therapeutic effects.
  • Epinephrine: Promethazine may reverse the vasopressor effect of epinephrine, leading to a further decrease in blood pressure (paradoxical effect).
🟡

Moderate Interactions

  • Antihypertensives: May cause additive hypotensive effects.
  • Metoclopramide: Additive risk of extrapyramidal symptoms.
  • Phenytoin: Promethazine may alter phenytoin metabolism.
  • QT-prolonging drugs: Theoretical additive risk of QT prolongation, though promethazine's effect is generally minor.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history (allergies, pre-existing conditions like asthma, glaucoma, prostatic hypertrophy, cardiovascular disease)

Rationale: To identify contraindications or conditions requiring caution.

Timing: Prior to administration

Medication reconciliation

Rationale: To identify potential drug interactions, especially with CNS depressants or anticholinergics.

Timing: Prior to administration

Baseline vital signs (BP, HR, RR)

Rationale: To establish baseline for comparison and identify potential adverse effects like hypotension or respiratory depression.

Timing: Prior to administration

📊

Routine Monitoring

Respiratory rate and depth

Frequency: Frequently, especially after initial dose and with concomitant CNS depressants; continuous monitoring in high-risk patients (e.g., children < 2 years, though contraindicated)

Target: Normal for age

Action Threshold: Bradypnea, shallow breathing, signs of respiratory distress (e.g., cyanosis, retractions)

Level of consciousness/Sedation score

Frequency: Regularly, especially after initial dose and with dose changes

Target: Desired level of sedation without excessive drowsiness or unresponsiveness

Action Threshold: Excessive sedation, somnolence, difficulty arousing

Injection site (for IM/IV administration)

Frequency: Before, during, and after administration; regularly thereafter

Target: No signs of irritation, pain, swelling, redness, or extravasation

Action Threshold: Pain, burning, swelling, redness, blistering, signs of extravasation or tissue necrosis (especially with IV)

Blood pressure and heart rate

Frequency: Periodically, especially in patients prone to hypotension

Target: Within patient's normal range

Action Threshold: Significant hypotension or tachycardia

đŸ‘ī¸

Symptom Monitoring

  • Excessive sedation or drowsiness
  • Dizziness or lightheadedness
  • Dry mouth
  • Blurred vision
  • Urinary retention
  • Constipation
  • Confusion or disorientation
  • Restlessness or agitation (paradoxical reaction)
  • Extrapyramidal symptoms (rare, e.g., dystonia, akathisia, parkinsonism)
  • Signs of respiratory depression (slow, shallow breathing, cyanosis)
  • Signs of tissue injury at injection site (pain, swelling, redness, blistering, necrosis)

Special Patient Groups

🤰

Pregnancy

Category C. Use only if the potential benefit justifies the potential risk to the fetus. Promethazine has been used in pregnancy for nausea and vomiting, but data are limited. Avoid use in late third trimester due to potential for platelet aggregation inhibition in the newborn and risk of respiratory depression.

Trimester-Specific Risks:

First Trimester: Limited human data, no clear evidence of increased risk of major birth defects.
Second Trimester: Limited human data, generally considered low risk if used cautiously.
Third Trimester: Avoid use in the last two weeks of pregnancy due to potential for neonatal respiratory depression, extrapyramidal symptoms, and platelet aggregation inhibition.
🤱

Lactation

L3 (Moderately safe). Promethazine is excreted into breast milk. While generally considered compatible with breastfeeding with caution, monitor the infant for sedation, irritability, or poor feeding. Avoid use in preterm infants or those with respiratory issues. Consider alternative agents if possible, especially with prolonged use.

Infant Risk: Sedation, irritability, poor feeding, respiratory depression (rare but serious, especially in neonates/preterm infants).
đŸ‘ļ

Pediatric Use

Contraindicated in children less than 2 years of age due to the risk of fatal respiratory depression. Use with extreme caution and at lower doses in children 2 years of age and older. Avoid concomitant use with other respiratory depressants. Risk of paradoxical excitation (restlessness, agitation) in some children.

👴

Geriatric Use

Use with caution due to increased susceptibility to anticholinergic effects (e.g., confusion, urinary retention, constipation, dry mouth, blurred vision), sedation, and orthostatic hypotension. Start with lower doses and titrate slowly. Avoid in elderly patients with dementia-related psychosis.

Clinical Information

💎

Clinical Pearls

  • Always confirm the route of administration: IM is preferred for injection due to the risk of severe tissue injury with IV extravasation. If IV, use a large, patent vein (preferably central line), dilute to 25 mg/mL, and administer slowly (no faster than 25 mg/minute). Avoid hand/wrist veins.
  • Promethazine is contraindicated in children under 2 years due to the risk of fatal respiratory depression. This is a critical Black Box Warning.
  • Be aware of the significant sedative and anticholinergic effects. Counsel patients to avoid driving or operating machinery and to avoid alcohol or other CNS depressants.
  • Monitor for paradoxical reactions (e.g., restlessness, agitation, nightmares) which can occur, especially in pediatric patients.
  • Promethazine can interfere with immunological pregnancy tests, causing false-negative or false-positive results.
  • May cause photosensitivity; advise patients to use sun protection.
🔄

Alternative Therapies

  • For nausea/vomiting: Ondansetron, Granisetron, Metoclopramide, Dimenhydrinate, Diphenhydramine
  • For allergic reactions: Diphenhydramine, Loratadine, Cetirizine, Fexofenadine
  • For sedation: Diphenhydramine, Hydroxyzine, Benzodiazepines (e.g., Lorazepam, Midazolam)
  • For motion sickness: Scopolamine, Dimenhydrinate
💰

Cost & Coverage

Average Cost: Varies widely by pharmacy and contract, typically $10-$50 per 1ml vial (25mg/ml)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or pour them down the drain. If you are unsure about the proper disposal method, consult your pharmacist for guidance. Many communities have drug take-back programs, which your pharmacist can help you locate. Some medications may come with an additional patient information leaflet; check with your pharmacist to see if this applies to your prescription. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.